Report on evidence for genetic testing in medicine

23 May 2011

It was noted that different stakeholders require different sorts of evidence, and that maintaining dialogue between them throughout development and evaluation of new genetic tests was important. The experts recommended that trials to generate evidence were increasingly required, but should be designed with reference to the specific clinical context for testing. Issues relating to clinical practice, health insurance reimbursement for genetic tests, and clinical research were also considered.

More from us

Genomics and policy news